Description
THIS REPORT:
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
Key Trends in Drug-Diagnostic Co-Development
Identifying collaborative opportunities and navigating regulatory challenges
Report Overview
The development of genomics-based ...(more)
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
Introduction
Targeted cancer therapies have achieved phenomenal growth, and many MAb-based immunotherapies are blockbusters
or mega-blockbusters. This market success is due not only to ...(more)
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets.
The focus of the report is on partnerships for busin...(more)
Description
Effective use of biomarkers at each stage of R&D can improve decision-making, increase clinical trial success rates and productivity and allow earlier stop/go decisions to be made, eliminating waste o...(more)
Description
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth stud...(more)
Description
THIS REPORT:
Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics
Offers a global analysis, with emphasis on U.S. data, and a fiv...(more)
Description
Introduction
Drug therapies for immune disorders span an enormous price range—from a few cents per day to tens of thousands
of dollars per year. Not surprisingly, payers impose restricti...(more)
Description
REPORT HIGHTLIGHTS
Description
In BMI’s updated Business Environment Rankings (BER) for Q109, Peru has slipped from second-last tolast position in the Americas matrix, thus remaining one of the least attractive pharmaceutical...(more)
Description
This benchmark research study assessed Marketing Staffing and Activity versus growth and margin rates across three segments - Branded Bio-Pharma Rx Products, Medical Devices, and Generic Products.
...(more)
Description
In today’s fast-changing, high-pressure marketplace, the Competitive Intelligence (CI) function helps companies anticipate external threats and opportunities in a timely manner so companies can ...(more)
Description
The purpose of this TriMark Publications report is to analyze and describe the nuclear cardiology market segments in the U.S. and worldwide. It examines the measurement devices that are utilized by ph...(more)
Description REPORT HIGHLIGHTS
- The global market for epigenomics was $161.8 million in 2005 and $263.2 million in 2006. The market will cross $385 million by 2007 and at a compound annual growth ...(more)
Description
An important milestone in the genomic era was reached in February 2001, when the Human Genome Project and Celera Genomics presented the initial sequencing and analysis of the human genome. Biotechnolo...(more)
Description
This report provides a historical review of drug discovery, and descriptions of the various genomic technologies used in drug discovery, such as genotyping and high-throughput screening (HTS). The rep...(more)
Description
Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price product...(more)
Description
Introduction
This analysis examines the historical and forecast performance for Merck-Serono in the ethical pharmaceutical sector. The profile encompasses global company strategy, port...(more)
Description This Health Industry Insights Perspective describes analyst perspectives on the implications of Merck's recent decision to acquire Sirna Therapeutics Inc. for $1.1 billion. Merck's expansion of it...(more)
Description
Introduction
This databook provides insight into the top 10 companies in the US life sciences industry in terms of their estimated IT spend.
Scope
Description
This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forec...(more)
Description
The field of therapeutic vaccines and immunotherapies is rapidly emerging as a promising area. Use of passive immunotherapy (i.e., antibody) products, for prevention of infection or for treatment of m...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
